Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. S100B and brain derived neurotrophic factor in monozygotic twins with, at risk of and without affective disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Is cesarean section a cause of affective disorders?-A national cohort study using sibling designs

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pattern recognition receptor polymorphisms in early periodontitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Lewis and AB0 blood group-phenotypes in periodontitis, cardiovascular disease, obesity and stroke

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Gasotransmitters and the immune system: Mode of action and novel therapeutic targets

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Maria Cristina Petralia
  • Emanuela Mazzon
  • Paolo Fagone
  • Maria Sofia Basile
  • Vittorio Lenzo
  • Maria Catena Quattropani
  • Klaus Bendtzen
  • Ferdinando Nicoletti
Vis graf over relationer

BACKGROUND: Immunoinflammatory disorders are often accompanied by depression. Here, we review the available preclinical and clinical studies suggesting a role for the pro-inflammatory cytokine Macrophage migration inhibitory factor (MIF) and the second member of the MIF family, D-dopachrome tautomerase (D-DT; DDT), in the pathogenesis of Major Depressive Disorders (MDD).

METHODS: We prepared a narrative review from a search on PubMed of studies pertaining to MDD and MIF, as for October 2019. Both humans and animal studies haves been considered.

RESULTS: Preclinical data show conflicting results on the role of endogenous MIF and DDT in depression. In contrast, several human studies show that circulating MIF levels tend to increase during the course of MDD. Higher levels of inflammatory biomarkers have also been associated with poorer responses to antidepressants and the levels of MIF significantly decrease after treatment, despite this may not be necessarily associated to an improvement in psychiatric symptoms.

LIMITATIONS: This is a narrative and not a systematic review of the literature on the involvement of MIF in MDD. We have highlighted studies performed in humans and in animal models, irrespective of population size and methodological approach.

CONCLUSIONS: This review highlights a role of MIF, and possibly DDT, in the pathogenesis of MDD. Whilst studies in animal models are discordant, the studies in patients with MDD convergently suggest that MIF plays a role in induction and maintenance of the disease. Additional studies are also needed on DDT that often displays synergistic function with MIF and their receptors.

OriginalsprogEngelsk
TidsskriftJournal of Affective Disorders
Vol/bind263
Sider (fra-til)15-24
Antal sider10
ISSN0165-0327
DOI
StatusUdgivet - 15 feb. 2020

Bibliografisk note

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

ID: 61866064